Enhancing immunogenicity of novel multistage subunit vaccine of Mycobacterium tuberculosis using PLGA:DDA hybrid nanoparticles and MPLA: Subcutaneous administration

OBJECTIVE(S): A new strategy in recent studies is using effective tuberculosis (TB) subunit vaccines combined with appropriate carriers and adjuvants which have shown promising results in preclinical and clinical studies. The aim of the present study was to evaluate the PLGA:DDA hybrid nanoparticles...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Iran J Basic Med Sci
Hlavní autoři: Khademi, Farzad, Yousefi, Arshid, Derakhshan, Mohammad, Najafi, Adel, Tafaghodi, Mohsen
Médium: Artigo
Jazyk:Inglês
Vydáno: Mashhad University of Medical Sciences 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6760476/
https://ncbi.nlm.nih.gov/pubmed/31579445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22038/ijbms.2019.33962.8079
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky